Torrent Pharma share price has plunged 4% and is presently trading at Rs 3,025.8.
Meanwhile, the BSE HEALTHCARE index is at 38,763.9 (up 0.1%).
Among the top losers in the BSE HEALTHCARE index today are DR. LAL PATHLABS (down 1.7%) and Dr. Reddys (down 0.8%).
HIKAL CHEMIC (up 4.0%) and Sanofi India (up 3.6%) are among the top gainers today.
Over the last one year, Torrent Pharma has moved up from Rs 1,941.8 to Rs 3,025.8, registering a gain of Rs 1,084.0 (up 55.8%).
On the other hand, the BSE HEALTHCARE index has moved up from 26,789.0 to 38,763.9, registering a gain of 44.7% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GSK Pharma (up 95.3%), Jubilant Pharmova (up 95.1%) and Lupin (up 92.7%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 80,190.2 (down 0.3%).
The top losers among the BSE Sensex today are Hindustan Unilever (down 2.7%) and Bajaj Finance (down 2.3%). The most traded stocks in the BSE Sensex are ITC and Tata Steel.
In the meantime, NSE Nifty is at 24,375.4 (down 0.4%). Hindustan Unilever and Tata Consumer Products are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,384.8 to 80,190.2, registering a gain of 13,805.4 points (up 20.8%).
Torrent Pharma net profit grew 20.9% YoY to Rs 4,570 million for the quarter ended June 2024, compared to a profit of Rs 3,780 million a year ago. Net sales rose 10.3% to Rs 28,590 million during the period as against Rs 25,910 million in April-June 2023.
For the year ended March 2024, Torrent Pharma reported 33.0% increase in net profit to Rs 16,564 million compared to net profit of Rs 12,452 million during FY23. Revenue of the company grew 11.5% to Rs 107,278 million during FY24.
The current Price to earnings ratio of Torrent Pharma, based on rolling 12 month earnings, stands at 59.0.
Equitymaster requests your view! Post a comment on "Torrent Pharma Plunges 4%; BSE HEALTHCARE Index Up 0.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!